Eyenovia appoints Drs. Strahlman and Palanki as independent directors, board expands to 8 seats

HYPERION DEFI, INC.

Both appointments effective July 1, 2022; board increases from 6 to 8 members.
Dr. Strahlman, former EVP R&D at BD and ex-CMO at GSK, joins audit and compensation committees.
Dr. Palanki, EVP Commercial Strategy at REGENXBIO with Santen/Genentech background, joins compensation committee.
Both directors determined independent under SEC and Nasdaq rules.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Ellen R. Strahlman

Director

HYPD · HYPERION DEFI, INC.

Effective: 2022-07-01
Filed: July 7, 2022, 7:59 PM ET

On July 1, 2022, the Board of Directors (the “Board”) of Eyenovia, Inc. (the “Company”) appointed Dr. Ellen R. Strahlman and Dr. Ram Palanki as members of the Board, effective immediately.

Appointed

Dr. Ram Palanki

Director

HYPD · HYPERION DEFI, INC.

Effective: 2022-07-01
Filed: July 7, 2022, 7:59 PM ET

On July 1, 2022, the Board of Directors (the “Board”) of Eyenovia, Inc. (the “Company”) appointed Dr. Ellen R. Strahlman and Dr. Ram Palanki as members of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Ellen R. Strahlman was appointed as Director at HYPERION DEFI, INC..

Action: appointed
Role: Director

Exact text from the filing

On July 1, 2022, the Board of Directors (the “Board”) of Eyenovia, Inc. (the “Company”) appointed Dr. Ellen R. Strahlman and Dr. Ram Palanki as members of the Board, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Ram Palanki was appointed as Director at HYPERION DEFI, INC..

Action: appointed
Role: Director

Exact text from the filing

On July 1, 2022, the Board of Directors (the “Board”) of Eyenovia, Inc. (the “Company”) appointed Dr. Ellen R. Strahlman and Dr. Ram Palanki as members of the Board, effective immediately.

View on SEC.gov

HYPERION DEFI, INC. filing history →

Source: SEC EDGAR

accession 0001104659-22-077920

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.